Results 191 to 200 of about 7,838 (234)
Some of the next articles are maybe not open access.

Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes

Diabetes Technology & Therapeutics
Objective: To evaluate the safety and explore the efficacy of use of ultra-rapid lispro (URLi, Lyumjev) insulin in the Tandem t:slim X2 insulin pump with Control-IQ 1.5 technology in children, teenagers, and adults living with type 1 diabetes (T1D ...
Carol J. Levy   +20 more
semanticscholar   +1 more source

108-LB: Ultrarapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs. Humalog (Lispro) in Healthy Chinese Subjects

Diabetes, 2021
URLi is a novel insulin lispro formulation developed to more closely match physiological insulin secretion. This randomized, subject-blind, 3‑period, crossover, 10‑h euglycemic clamp study assessed the pharmacokinetics (PK), glucodynamics (GD) and ...
Ye-Rong Yu   +6 more
semanticscholar   +1 more source

Effects of treatment with lispro and neutral protamine Hagedorn insulins on serum fructosamine and postprandial blood glucose concentrations in dogs with clinically well-controlled diabetes mellitus and postprandial hyperglycemia.

American Journal of Veterinary Research, 2020
OBJECTIVE To assess effects of basal-bolus insulin treatment (BBIT) with lispro and neutral protamine Hagedorn (NPH) insulins, compared with NPH insulin alone, on serum fructosamine concentration (SFC) and postprandial blood glucose concentration (BGC ...
A. Bertalan, K. Drobatz, R. Hess
semanticscholar   +1 more source

Application of the capillary zone electrophoresis (CZE) and capillary gel electrophoresis (CGE) for the separation of human insulin, insulin lispro and their degradation products.

Pharmazie, 2020
Two capillary electrophoresis (CE) methods have been developed for the separation of charge and mass variants of human insulin and its recombinant analogue lispro.
B. Pajaziti   +3 more
semanticscholar   +1 more source

Insulin Lispro

New England Journal of Medicine, 1997
F, Holleman, J B, Hoekstra
  +5 more sources

BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study

Diabetes, obesity and metabolism, 2019
We investigated the pharmacodynamics (PD) and pharmacokinetics (PK) of BioChaperone insulin Lispro (BCLIS), faster insulin aspart (FIA) and insulin aspart (ASP) in patients with type 1 diabetes using an insulin pump.
T. Heise   +12 more
semanticscholar   +1 more source

Insulin-lispro

Reactions Weekly, 2022
openaire   +1 more source

[Insulin lispro].

Nihon rinsho. Japanese journal of clinical medicine, 2002
The results of the clinical studies of insulin lispro carried out in Japan to confirm the pharmacodynamics, pharmacokinetics, efficacy and safety, which were recently released were summarized in this article. When compared to human regular insulin, single subcutaneous injection to healthy persons showed that insulin lispro was adsorbed and disappeared ...
openaire   +2 more sources

Insulin lispro

Reactions Weekly, 2018
Shriya Patel, Shuchismita Dutta
openaire   +2 more sources

Home - About - Disclaimer - Privacy